Investigating the Immediate Effects of Kinesio Tape and Biomechanical Tape on Strength and Performance: A Randomized Placebo-Controlled Cross-Over Trial

April 27, 2025 updated by: Mirsad ALKAN, Bahçeşehir University
There has been an increasing interest in Kinesiology Tape(KT) and Biomechanical Tape(BT) in clinics and athletic competitions. Recently; the performance increasing effect of taping methods on healthy subjects in sports is being investigated.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Kinesio Taping (KT) is a technique utilizing a two way elastic tape originally created by Kenzo Kase in the 1970s. KT is a complementary method which is used as an adjunct to major therapy approaches in various musculoskeletal and neurological diseases.4 KT is employed in sports injuries and various health problems; but there is limited scientific evidence evaluating KT effectiveness and the results are inconsistent.5 One of the KT potential benefits is that of raising the range of motion through increasing blood circulation or through stimulation of cutaneous mechanoreceptors and this way it affects fascial tissue.6-8 Biomechanical Taping (BT) is a technique utilizing a four way elastic tape originally created by Ryan Kendrick in the 2010s. BT is a complementary method for supplementing load absorption, force contribution and modifying movement. BT affects tissues and movement in a mechanical way and it is almost a completely different method from KT. Kase's hypothesis is that KT affects fascial tissues and mechanoreseptors, but Kendrick's hypothesis is that BT ,which is applied in shortened position and cross joint segments, will gain potential energy in case of an extremity realized movement with antagonist activity. Then the weak agonist muscle gets activated for repositioning the extremity; this potential energy turns to kinetic energy like a released bow. As a result of kinetic energy, it may support the movement with using passive mechanical strength.9 In this study, the investigators aim to illustrate immediate effects of various taping methods on the performances of healthy subjects. In that way the investigators test hypothesis that different taping methods affect healthy subjects to improve performance. The investigators; investigate strength, active range of motion and vertical jump height as a parameters of performance with No Tape(NT), Sham Tape(ST), KT and BT.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
20

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Beşiktaş
      • İstanbul, Beşiktaş, Turkey, 34353
        • Bahcesehir University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 24 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-24 BMI
  • Physically active according to International Physical Activity Questionnarie (IPAQ)

Exclusion Criteria:

  • Any known systemic diseases or medical condition
  • Sensitive or fragile skin,
  • Allergic diseases
  • Pregnancy or pregnancy suspicion
  • Using of sedative, psychosomatic or analgesic drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: Control
Tests were applied with any taping.
Sham Comparator: Sham Taping
In ST stage; medical purpose, hypoallergenic OctaCare® Rigid Transparent Plaster was applied as a rigid tape. This tape is also used under rigid tapes for protecting the skin. In this study investigators didn't prefer extra rigid tape on the plaster because that was very light and less sensitive material to our knowledge so it suited our aim of placebo control.
Other: Rigid Tape
Non-Elastic Tape
Experimental: Kinesiology Taping
In KT stage; the original Kinesio Tex® Tape Classic was applied as a kinesiology tape. In this study, investigators applied the tape with muscle activation technique and paper of tension (it was declared %10) according to Kenzo Kase's Kinesio Taping concept. It was implemented on both bileral Rectus Femoris and Calf muscles with same technique.
Other: Kinesiology Tape
Tape can be elongate only one direction
Experimental: Biomechanical Taping
In BT stage; Dynamic Tape® was applied as a biomechanical tape. In this study, investigators applied the tape with offload technique and paper of tension according to Ryan Kendrick's Biomechanical Taping concept. It was implemented on both bileral Rectus Femoris and Calf muscles with same technique.
Other: Biomechanical Tape
Tape can be elongate only two direction

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change From Vertical Jump With Each Taping Application
Time Frame: baseline, and immediate effect in a 15 minutes
A fotoelectrical sensor base "Micro Gate Opto Jump Next®, software version 1.10, BFS Vertical Jump protocol with three jumps" was used for quantitative analysis of Counter Movement Vertical Jump (CMVJ). Minimum, maximum and average values of jumping height for all jumps (10) were recorded as canti-meter (cm).
baseline, and immediate effect in a 15 minutes
Change From Muscle Strength With Each Taping Application
Time Frame: baseline, and immediate effect in a 15 minutes
A hand held electronic dynamometer "MicroFet® 2" was used to evaluate isometric bilateral knee extension and ankle dorsal flexion strength.11 Measurements were repeated three times and maximum value of strength was recorded as Kilogram-Force (Kg-F).
baseline, and immediate effect in a 15 minutes

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Change From Active Range Of Motion With Each Taping Application
Time Frame: baseline, and immediate effect in a 15 minutes
A wide angle webcam "logitech® c920 full hd pro web cam" that was integrated with opto jump software was used for assessment of active range of motion in front of jumping on image based assessment tool of opto jump software. Acromion, Trochantor major of femur, lateral epicondyle of femur, Lateral Condyle of Tibia and medial malleolus of tibia were marked for the indicator before the jumps. Videos, recorded at the same time with jump and synchronous with jumping values, were used for resolving knee and hip flexion degrees before jump with maximum height and they were assessed with indicators on computer surface on optojump software. Values recorded as degrees (º).
baseline, and immediate effect in a 15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Bahçeşehir University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Habibe Serap İnal, Bahcesehir University
  • Principal Investigator: Şebnem Nur Alkan, Bahcesehir University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 3, 2016

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 12, 2017

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 12, 2017

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 29, 2019

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 13, 2019

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 16, 2019

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 30, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 27, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 52

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings